Thairm Bio

Glasgow-based medical start-up Microplate Dx has successfully closed a £2.5 million seed funding round to accelerate the development of its point-of-care diagnostic platform. The technology aims to combat antimicrobial resistance (AMR) by quickly identifying the most effective antibiotics for

Dxcover — a Glasgow-based company developing a blood test that can detect cancer at an early stage — has raised £9.7 million through a Series A investment round and grant funding. The £7.5m funding round was led by existing investors Eos Advisory LLP, Mercia Asset M

Glasgow-based Talking Medicines, the world’s first Artificial Intelligence (AI) driven patient intelligence company designed to meet the needs of pharma, has closed a £1.5 million funding round to support its ambitions for expansion into the US. Boston based life science investor Mark Ba

St Andrews-based Pneumagen, a clinical-stage biotech company, has raised £3.8 million to advance clinical development and manufacturing of its lead product Neumifil. The financing round was co-led by existing investors, Thairm Bio and Scottish Enterprise.

A round-up of business news from across Scotland featuring: Alpha Solway's visor production for the NHS, Edinburgh Gin's new Gin Fizz, Smarter Grid Solutions' £20 million R&D milestone, Sunamp's £50,00 grant from Innovate UK, Pneumagen's £4m invest